PersonalisvsThermo Fisher Scientific

PSNL and TMO stock compared: price, dividend, valuation and results, from SEC filings.

TMO

Thermo Fisher Scientific Inc

$700.22

Value $260B

+0.11%
TMO's page

Personalis (PSNL) has a market value of $1.6B and Thermo Fisher Scientific (TMO) $260B. Over the last year, with dividends, PSNL moved +96.1% and TMO +19.5%. Dividend yield: PSNL none, TMO 0.26%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    PSNL$1.6B

    TMO$260B

    TMO is 158 times PSNL

  • Revenue, 12 months

    PSNL$81M

    TMO$47.4B

    TMO is 586 times PSNL

  • Net income, 12 months

    PSNL-$119M

    TMO$7.1B

  • Operating margin

    PSNL-156.7%

    TMO17.9%

    174.6 points apart

  • ROIC

    PSNL-43.8%

    TMO8.2%

    52.0 points apart

  • P/E

    PSNL–

    TMO36.8

  • Dividend yield

    PSNL0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    PSNL-14.6%

    TMO+11.8%

    26.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

PSNL-14.6%

TMO+11.8%

05010020222023202420252026
Returns by period
PeriodPSNLWith dividendsTMOWith dividends
1 year since November 12, 2025+96.1%Price +96.1%+19.5%Price +19.1%
3 years since November 13, 2023+1,368.2%+144.9% a yearPrice +1,368.2%+58.8%+16.7% a yearPrice +57.3%
5 years since November 12, 2021-14.6%-3.1% a yearPrice -14.6%+11.8%+2.3% a yearPrice +10.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

PSNLPersonalisTMOThermo Fisher Scientific

Valuation

PSNLTMO
Valuation
Price$15.71$700.22
Market value$1.6B$260B
Enterprise value (EV)$1.5B$295B
P/E–36.8
P/E, 5-year median–32.7
P/B7.74.8
EV/EBIT–34.9
Free cash flow yield–2.9%

Results and growth

PSNLTMO
Results and growth
Revenue, 12 months$81M$47.4B
Net income, 12 months-$119M$7.1B
Free cash flow, 12 months-$108M$7.6B
Earnings per share, 12 months-$1.17$18.96
Revenue growth, year on year-17.7%3.9%
Revenue growth a year, past-2.4%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

PSNLTMO
Margins and returns on capital
Gross margin16.7%–
Operating margin-156.7%17.9%
Net margin-147.7%14.9%
ROIC-43.8%8.2%
ROE-52.6%13.4%

Balance sheet

PSNLTMO
Balance sheet
Cash$191M$6.1B
Total debt$37M$41.4B
Net debt / EBITDA–3.7
Interest cover-684.0×5.5×

Dividends and buybacks

PSNLTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: PSNL or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Personalis or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($260B) is about 158.2 times Personalis ($1.6B), at today's prices.

How did PSNL and TMO stock do over the last 5 years?

Since November 12, 2021, PSNL's price moved -14.6% and TMO's +10.2%. With dividends: PSNL -14.6% (-3.1% a year), TMO +11.8% (+2.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, PSNL or TMO?

The dividend yield at today's price is none for Personalis and 0.26% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which has the higher profit margins, Personalis or Thermo Fisher Scientific?

Over the last twelve months, the net margin was -147.7% for Personalis and 14.9% for Thermo Fisher Scientific, and the operating margin -156.7% and 17.9%. Revenue was $81M and $47.4B.

Which is the better investment, Personalis or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.